Together we will beat cancer

Donate

Targeted drug recommended to treat some advanced lung cancer patients

Selpercatinib will expand treatment options available for people with RET fusion positive non small cell lung cancer on the NHS in England.

Read More

First targeted treatment approved for advanced prostate cancer on NHS in Scotland

The targeted drug olaparib has been approved for some people with a type of advanced prostate cancer on the NHS in Scotland.

Read More

Cancer Won’t Wait: “I prayed she would see her daughter start school”

We spoke to 4 people about why, when it comes to cancer, every second counts and why the Government must act now to ensure the NHS can catch more cancers early.

Read More

Cancer target missed for 55,000 patients over 6 years

In the last 6 years, almost 55,000 cancer patients should have been diagnosed or started their treatment sooner, according to new calculations.

Read More

NHS lung cancer patients in England get early access to ‘breakthrough’ cancer drug

The Medicines and Healthcare products Regulatory Agency has approved the first-of-its-kind drug sotorasib for some people with non small cell lung cancer.

Read More

NHS England change of chief executive – what does it mean for cancer?

Our chief executive, Michelle Mitchell, reflects on his cancer legacy and the challenges still facing Amanda Pritchard as she steps into the role.

Read More

Opinion: ‘We’re speaking with One Cancer Voice, but is anyone listening?’

We joined 46 other cancer charities to outline what we need from UK Governments and the NHS coming out of the pandemic to move towards world-leading services.

Read More

2,000 fewer people in England began cancer treatment in January

The latest cancer waiting times show an 8% drop in the number of people starting cancer treatment in January, compared with figures from January 2020.

Read More

Potentially life-extending treatment for lung cancer available in England

A potentially life-extending treatment for some people with non small cell lung cancer (NSCLC) will now be available on the NHS in England.

Read More

Cancer services during COVID-19: 40,000 fewer people starting treatment

There’s been a steady stream of figures since the pandemic began, each laying bare what many people have seen first-hand – the impact on health services.

Read More